Improving pharmaceutical synthesis through innovative chemical methods
Official title: Supramolecular Dual Substrate Activation: Synthetic Methods via Coencapsulation
Funded at University of California Berkeley · NIH-11019696 · Data updated 2026-11-12
This study is exploring new ways to make medicines more effectively by using special techniques that help ingredients work better together, which could lead to improved treatments for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project start | January 10, 2024 |
| Project end | January 9, 2026 |
| Funding year | 2025 |
| Award (this year) | $74,284 |
| NIH project number | 5F32GM153093-02 |
| Project ID | NIH-11019696 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be individuals seeking new treatment options for various health conditions that could be addressed by novel pharmaceuticals.
✕Less likely to help
Patients with conditions that are not targeted by the specific pharmaceutical advancements resulting from this research may not receive any benefit.
What this research studies
This research focuses on developing new synthetic methods in organic chemistry to enhance the production of pharmaceuticals. By utilizing supramolecular catalysis, the project aims to create novel molecular structures that can lead to more effective drug therapies. The approach involves coencapsulating two reagents within a host to improve their reactivity, mimicking the efficiency of natural enzymes. Patients may benefit from the resulting advancements in drug development that could lead to better treatment options.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and innovative pharmaceutical therapies.
How similar studies have gone: Previous research in supramolecular catalysis has shown promising results, indicating that this approach could lead to significant advancements in pharmaceutical synthesis.
Where this research is happening
-
University of California Berkeley
Berkeley, United States Active
Researchers
- Principal investigator: Treacy, Sean Michael — University of California Berkeley
- Study coordinator: Treacy, Sean Michael
Related research
Other NIH-funded projects on the same topics.
-
Mobile AI-powered microscope to quickly spot parasites in wastewater
A new AI-enabled mobile microscope will be tested to quickly detect parasite eggs in wastewater from refugee settings to help protect public health.
-
SCAN: Standardized brain imaging for Alzheimer’s and related dementias
A nationwide effort to standardize brain imaging data in people with Alzheimer’s and related dementias so researchers can compare results and learn how to diagnose and track the disease.
-
Cerebellum’s role in thinking and behavior across tasks
This grant explores how the cerebellum helps people think, feel, and behave across different tasks, with a focus on understanding cognitive and affective processing in cerebellar disorders.
-
Genetic clues to how teeth form and replace themselves in sticklebacks
A study in a fish model aims to uncover the genetic factors that control how teeth form and keep renewing, with potential implications for human tooth regeneration.
-
California Abundant Birth Project: does guaranteed income during pregnancy affect birth outcomes and child development?
A government-backed program gives pregnant people in California monthly income to reduce stress, with researchers studying how this helps birth outcomes and early child development.
-
American-Asian Arbovirus Research and Enhanced Surveillance Center
A2CARES is a national program that brings together scientists across disciplines to improve detection, study, and response to arthropod-borne viruses affecting adults in the Americas and Asia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.